Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-21.35	34.41	43.76
Graham Fair Price	-29.31	0.87	1.22
PEG	2991.82	-0.13	< 0.005
Price/Book	0.23	0.95	0.94
Price/Cash Flow	286.16	-35.94	9.31
Prices/Earnings	105.04	19.32	-9.42
Price/Sales	38.95	4.64	3.34
Price/FCF	286.16	-35.94	9.31
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	9.79	0.22	0.20
Operating Margin	-53.14	0.11	-0.24
ROA	-50.29	< 0.005	< 0.005
ROE	-0.03	0.01	-51.12
ROIC	-0.06	< 0.005	-82.95
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	0.04	-51.75
Dividends QOQ	3.55	-0.53	-85.05
EBIT QOQ	-5.80	1.34	-76.85
EPS QOQ	-22.53	1.49	-93.37
FCF QOQ	31.00	-1.26	-95.93
Revenue QOQ	0.28	-0.27	-4.89
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	319.35	455.58	42.66
Days Sales Outstanding (DSO)	65.11	99.27	52.46
Inventory Turnover	0.28	0.20	-29.90
Debt/Capitalization	0.34	0.33	-2.11
Quick Ratio	0.76	0.80	5.00
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.63	1.65	1.10
Cash	0.99	0.99	-0.25
Capex	-0.05	< 0.005	83.39
Free Cash Flow	0.17	-0.04	-73.76
Revenue	0.46	0.34	-27.08
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.58	1.61	1.88
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-3.84	-1.27	67.04
Naive Interpretation	Member

06 - Financial Health · Weak

Rating